Table 2.
Parameters | Patients with positive fecal tests (n = 20) | Patients with negative fecal tests (n = 49) | P value |
---|---|---|---|
Symptoms | |||
Fever |
10 (50.00 %) | 37 (75.51 %) | 0.039 |
Dry cough | 9 (45.00 %) | 20 (40.82 %) | 0.749 |
Cough with sputum | 6 (30.00 %) | 21 (42.86 %) | 0.321 |
Muscle ache | 2 (10.00 %) | 13 (26.53 %) | 0.235 |
Sore throat | 4 (20.00 %) | 5 (10.20 %) | 0.483 |
Breathlessness | 0 | 6 (12.24 %) | 0.243 |
Chest tightness | 5 (25.00 %) | 8 (16.33 %) | 0.619 |
Fatigue | 4 (20.00 %) | 13 (26.53 %) | 0.568 |
Headache | 2 (10.00 %) | 6 (12.24 %) | 1 |
Nausea and vomiting | 1 (5.00 %) | 7 (14.29 %) | 0.497 |
Diarrhea | 5 (25.00 %) | 7 (14.29 %) | 0.474 |
Laboratory results | |||
CRP, 0∼8 mg/L | 2.935 (0.90–8.77) | 13.9 (4.29–43.03) | 0.001 |
>8 | 6 (30 %) | 32 (65.31 %) | 0.007 |
Leukocyte counts4 −10 × 10^9/L |
4.925 (3.9–5.62) | 4.89 (4.35–5.95) | 0.579 |
>10 | 0 | 2 (4.08 %) | 0.9 |
Neutrophil counts 1.8-6.3 × 10^9/L |
2.85 (2.055–3.48) | 3.13 (2.50–4.11) | 0.203 |
>6.3 | 1 (5 %) | 3 (6.12 %) | 1 |
Lymphocyte counts 1.1–3.2 × 10^9/L |
1.50 (1.18–1.70) | 1.34 (1.01–1.44) | 0.12 |
<1.1 | 3 (15 %) | 17 (34.69 %) | 0.102 |
ALT, 0–69 IU/L | 33.5 (24.5–51.5) | 29 (21.0–38.0) | 0.309 |
>69 | 0 | 5 (10.20 %) | 0.331 |
ALB, 35−55 g/L | 39.45 (38.425–41.35) | 38.5 (35.1–39.9) | 0.071 |
<35 | 1 (5 %) | 10 (20.41 %) | 0.221 |
FIB, 2.00–4.00 g/L | 4.02 (3.505–4.85) | 5.15 (3.56–5.905) | <0.001 |
>4 | 10 (50 %) | 45 (91.84 %) | <0.001 |
D-dimer, 0-0.5 μg/L | 0.33 (0.22-0.5225) | 0.43 (0.32-0.69) | 0.136 |
>0.5 | 5 (25 %) | 22 (44.90) | 0.124 |
Chest CT | |||
Unilateral | 4 (20 %) | 6 (12.24 %) | 0.169 |
Bilateral lung nvolvement | 15 (75 %) | 42 (85.71) | |
No abnormal density shadow | 1 (5 %) | 1 (2.04 %) |
Data are presented as interquartile ranges (IQRs), numbers and percentages.
CRP, C-reactive protein; ALT, alanine transaminase; ALB, albumin; FIB, Fibrinogen.